Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
detroit blog main
7
×
detroit top stories
life sciences
7
×
national blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
national
clinical trials
amgen
cancer
fda
cholesterol
diagnostics
europe blog main
europe top stories
hepatitis b
immunotherapy
medicaid
medicare
merck
What
drug
7
×
fda
approved
bio
cholesterol
lowering
market
new
patients
plan
roundup
therapeutics
acquisitions
advantages
agency
aimmune
allergy
anathema
approval
awaited
awarded
bar
biggest
brings
build
buy
cancer
ceo
combo
company’s
daniel
debut
democrat
details
developed
drugs
dyne’s
eisai
elements
esperion
Language
unset
7
×
Current search:
drug
×
biotech
×
" detroit blog main "
×
" life sciences "
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)